Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading JAZZ News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.06%10.759.9%$297.33m
PRGOPerrigo Co. Plc
-0.29%67.964.8%$179.65m
SHPGShire PLC Sponsored ADR
0.70%175.230.3%$161.46m
MDCOMedicines Company
1.40%50.6922.6%$134.46m
ENDPEndo International Plc
-0.20%9.978.9%$131.03m
JAZZJazz Pharmaceuticals Plc
0.45%143.141.9%$89.29m
MNKMallinckrodt Plc
-0.21%43.0912.8%$86.79m
UTHRUnited Therapeutics Corporation
0.66%140.0511.5%$85.74m
PRXLPAREXEL International Corporation
0.86%62.356.7%$70.21m
PCRXPacira Pharmaceuticals, Inc.
-0.11%46.9016.9%$67.17m
PTLAPortola Pharmaceuticals, Inc.
0.55%38.4410.3%$48.48m
ICPTIntercept Pharmaceuticals, Inc.
0.80%116.7322.8%$45.29m
HZNPHorizon Pharma plc
-1.31%14.379.7%$45.07m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.04%121.179.9%$39.39m
ICLRICON Plc
1.73%78.942.8%$38.72m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.